111 Capital’s HCA Healthcare HCA Stock Holding History

111 Capital’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,564	Closed	-$740K	–	548
2026 Q1	$740K	Buy	1,564 +96	+7%	+$48.3K	0.18%	112
2025 Q4	$685K	Buy	1,468 +589	+67%	+$273K	0.15%	119
2025 Q3	$375K	Buy	+879	New	+$341K	0.07%	266

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

111 Capital's HCA Position: Q2 2026 in Review

111 Capital sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 1,564 shares — an estimated $740K sold.

111 Capital first reported a position in HCA in Q3 2025 and held it in 3 quarters. The position peaked at $740K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

111 Capital reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
111 Capital sold 1,564 HCA Healthcare shares in Q2 2026, an estimated $740K.
111 Capital first reported a position in HCA Healthcare in Q3 2025 and held it in 3 quarters.
111 Capital's HCA Healthcare position peaked at $740K in Q1 2026.
1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.